A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain

British Journal of Cancer

Volumn 111, Issue 9, 2014, Pages 1831-1835

  Waller, J ^a   Whitaker, K L ^a   Winstanley, K ^a   Power, E ^b   Wardle, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

cancer screening; mammography; overdiagnosis; risk communication

Indexed keywords

ADULT; AWARENESS; BEHAVIOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; COMPREHENSION; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OVERDIAGNOSIS; REVIEW; SOCIAL STATUS; UNITED KINGDOM; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FOLLOW UP; INFORMATION PROCESSING; MAMMOGRAPHY; MIDDLE AGED; PATIENT ATTITUDE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; DATA COLLECTION; DIAGNOSTIC ERRORS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROGNOSIS;

EID: 84908512326     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.482     Document Type: Review

References (13)

1. Duffy SW, Tabar L, Olsen AH (2010) Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 17(2): 106.
2. Gotzsche PC, Jorgensen KJ (2011) The breast screening programme and misinforming the public. J R Soc Med 104(9): 361-369.
3. Hawkes N (2012) Women "jurors" are asked how to present risk-benefit ratio of breast cancer screening. BMJ 345: E7886.
4. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, Dhillon H, McCaffery K (2013) Women's views on overdiagnosis in breast cancer screening: A qualitative study. BMJ 346: F158.
5. IBM Corp (2011) Released 2011. IBM SPSS Statistics for Windows, Version 20.0. IBM Corp: Armonk, NY, USA.
6. Independent UK Panel on Breast Screening (2012) The benefits and harms of breast cancer screening: An independent review. Lancet 380(9855): 1778-1786.
7. Informed Choice about Cancer Screening. Retrieved 21 May (2014) from http://www.informedchoiceaboutcancerscreening.org.
8. NHS (2013) NHS breast screening: Helping you decide. Retrieved 21 May 2014 from http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp.pdf.
9. Schwartz LM, Woloshin S, Fowler FJ, Welch HG (2004) Enthusiasm for cancer screening in the United States. JAMA 291(1): 71-78.
10. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, King J, Lawson ML, Linder SK, Lipkus I, Ozanne E, Peters E, Timmermans D, Woloshin S (2013) Presenting quantitative information about decision outcomes: A risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak 13(Suppl 2): S7.
11. Waller J, Douglas E, Whitaker KL, Wardle J (2013) Women's responses to information about overdiagnosis in the UK breast cancer screening programme: A qualitative study. BMJ Open 3(4): Doi:bmjopen-2013-002703.
12. Welch HG, Passow HJ (2014) Quantifying the benefits and harms of screening mammography. JAMA Intern Med 174(3): 448-454.
13. Woloshin S, Schwartz LM, Welch HG (2005) Patients and medical statistics-Interest, confidence, and ability. J Gen Intern Med 20(11): 996-1000.